: Dec. 24, 2018 (HealthDay News) :Two common class types of diabetes can reduce the level of blood sugar, but new research shows that as soon as the drug can increase the risk of heart attack, stroke and heart failure.
In the question, drugs are sulfuroveruras and basal insulin. Sulfuriales cause the body to release more insulin. They are verbally taken and used for the 1950s. Basal insulin is given as an injection, and it is engineered to slowly dissolve the whole day.
Meanwhile, this study was found that modern and generally more expensive drugs are available to reduce the risk of heart disease and stroke.
Dr. Matthew Oberen, author of study, said the new results about a “paragraph shift” say how we are dealing with diabetes. ”
At present, 2 types of diabetes are given metformin, and if they require one another, they often give sulfonyornas or basal insulin. But these results call this process in question.
“Those who started taking sulfonynoras and basal insulin, there are many acne cases of pain. So, if all new drugs are under the risk of low-pollution, then we first treat 2 types of diabetes. Should go to, “Oberen explained. He is Assistant Professor of General Internal Medicine, Journal and Prevention Institution in the Northwestern University of Fenerbang School of Medicine in Chicago.
But it does not seem to be in the process. “Only 10% of 15 percent of patients are being treated with new diabetes medicines,” said Andrew Zellenziez, director of clinical diabetes center, at the Matphire Medical Medical Center in New York City.
“Most patients are receiving medicines that are less effective and can potentially cause heart problems,” Zelzesey said.
According to the information from the American Diabetes Association (ADA), there are approximately two dozen different diabetes medicines. Oberen and his colleagues started this study as it is not a strong consensus, to use many drugs, if standard first-line treatment does not work.
“When we diagnose people with 2 types of diabetes, we comply with them because all this specialist has recommended. But if metaphoramum is no longer affected or is a patient’s disease, What is the dealer to treat with this next? Nobody knows what’s better. We want to explain what the next best medicine is, “Oberen said.
This type of study was present in the number of 130,000 ill adults with 2 diabetes who twice started a therapy with anti-diabetes medicines. This information reaches from USA to disease from 2011 to 2015.
The study participants had 45 to 64 years, and the average pursuit was 1.3 years.
Treatment with medicinal treatment known as DPP-4 influenza (Geneva, Tradjena, Ongazia), SGLT-2 Infrastructure (Inquuka, Forexa, Jaration) and GLP-1 agonists (Beth, Trulicity, Victoza ) Were almost connected to a 20%. The risk of complications, such as heart disease and shock.
Sophoneonicosis was more than 36% of complicated complications, whereas basal insulin had almost linked to heart disease and stroke complexity almost twice.
O’Brien said the study is being observed because it can not prove whether there are medicines or problems with those who cause a growing heart risk. People who took insulin started getting ill, which could affect these results. However, researchers account for many factors, such as ages, blood sugar control and other diseases to control data.
O’Brien thinks that the process should change now. He said I think there is enough evidence from our studies and others that Sulfonnosis and Basal insulin should not be the default for the second choice.”
Zanseyzi agreed and expressing the benefits of new drugs, he suggested that he should be used soon later.
“I think initially newer diabetes can be used with metermenic drugs,” said Zansziez. It helps with a decrease in weight loss, they really do not make hugoglycemia [blood loss] and they Help prevent heart disease. ”
However, Buren emphasized that a doctor should stop taking medicine without talking to him. Instead, he said that you have to communicate with your doctor and ask if your current medicine is the best choice for you or not. If this is an insurance payment case, he said that your doctor may be able to work with your insurance company so that you get a new diabetic medication, if it is the best choice for you.
Examples of sulfonyuras include chloride proteid (dababine), glyceride (molecular), glucose (glucose) and glyloid (micronesis, glycase, and diabetes). Examples of basal insulin include glargine (Lantus, Toujeo), detemir (Levemir) and degludec (Tresiba).